Q2 2026 Resmed Inc Earnings Call Transcript
Key Points
- ResMed Inc (RMD) reported an 11% headline revenue growth, with a 9% increase on a constant currency basis.
- The company achieved a 16% growth in GAAP EPS, indicating strong bottom-line performance.
- ResMed Inc (RMD) experienced high single-digit growth in global devices revenue and double-digit growth in global masks, accessories, and other revenue.
- The company reported a 310 basis points year-over-year gross margin expansion, driven by component cost improvements and manufacturing efficiencies.
- ResMed Inc (RMD) continues to innovate with new product launches, such as the F30i Comfort and F30i Clear fabric masks, receiving positive feedback from patients and providers.
- SG&A expenses increased by 15% on a headline basis, outpacing revenue growth, primarily due to employee-related expenses and marketing investments.
- The effective tax rate increased to 21.1% from 18% in the prior year, impacting net income growth.
- ResMed Inc (RMD) recorded a $6 million restructuring-related charge, reflecting global workforce planning activities.
- The company's residential care software business faced ongoing challenges in the senior living and long-term care verticals.
- Despite strong performance, the company faces potential competition from Philips' re-entry into the US device market, which could impact market dynamics.
Greetings, and welcome to the ResMed second quarter fiscal year 2026. (Operator Instructions). As a reminder, this conference is being recorded.
It's now my pleasure to turn the call over to Salli Schwartz, Chief Investor Relations Officer. Please go ahead.
Thanks, Kevin. I want to welcome our listeners to ResMed's second quarter fiscal year 2026 earnings call. We are live webcasting this call, and the replay will be available on the Investor Relations section of our corporate website later today. Our earnings press release and presentation are both available online now.
During today's call, we will discuss several non-GAAP measures that we believe provide useful information for investors. This information is not intended to be considered in isolation or as a substitute for GAAP financial information. We encourage you to review the supporting schedules in today's earnings press release to reconcile these non-GAAP measures with the GAAP reported numbers.
In addition, our
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
